RxDoctor Payments Data

Kelly Smith, NP

Nurse Practitioner · Kalamazoo, MINPI 1528035078

Payments from drug & device makers

$2,074in general payments, 2019–2025

Across 77 payments — averaging $26.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$466
  • Novartis$282
  • Gilead$193
  • Lilly USA, LLC$137
  • Merck$127
  • Pharmacyclics LLC, An Abbvie Company$99
  • plus $770 from 18 others

What the payments were for

  • Food & beverage$1,27962%
  • Education$79538%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,074 in reported general payments places this provider in the 85th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Medicare billing

Part B allowed, 2024
$17,764
Medicare patients
159
Services billed
283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IbrancePalbociclib33$504,291
PiqrayAlpelisib12$162,305
VerzenioAbemaciclib11$105,602
Abiraterone Acetate25$69,033
EliquisApixaban16$13,452
XareltoRivaroxaban14$11,067
Anastrozole147$6,443
Exemestane23$3,680
Letrozole77$3,488
Tamoxifen Citrate36$1,116
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$550
Potassium Chloride15$417
Gabapentin29$293
Dexamethasone11$283
Oxycodone Hcl13$200

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisPiqray$282$162,30512 claims
Lilly USA, LLCVerzenio$137$105,60211 claims
Johnson & JohnsonXarelto$52$11,06714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Kalamazoo

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →